News – Page 8 – Endpoints News

Enzene, Veranova separately unveil expansions; Lotte's new ADC client

3 weeks ago

Roche's venture arm chief to step down in 2026; AstraZeneca obesity leader has retired

3 weeks ago

FDA's top cell and gene therapy leaders exit agency in ongoing CBER changes

3 weeks ago

Grail shares jump on study results for cancer test

3 weeks ago

Gilead gets groundbreaking FDA approval for twice-yearly HIV prevention shot

3 weeks ago

Compounders lose case over semaglutide shortage

3 weeks ago

Zealand study shows higher GLP-1/GLP-2 doses may lead to greater weight loss

3 weeks ago

CBER head Prasad adds chief medical and scientific officer to his title

3 weeks ago

Q&A: New BIO chair to steer industry through ‘existential threats’ despite FDA receptivity

3 weeks ago

BioNTech stops making cell therapy at Maryland site after dropping germ cell tumor indication

3 weeks ago

How a tailored ALS drug could help broaden rare disease therapies

3 weeks ago

Scholar Rock’s muscle-preserving obesity drug add-on looks competitive

3 weeks ago

Tennr raises $101M Series C to fix faxes with AI

3 weeks ago

Humana details plans to grow its primary care business as competing clinics shutter

4 weeks ago

Bavarian Nordic's PRV goes for $160M; Biomea to advance GLP-1 into trials

4 weeks ago

Watch Post-Hoc Live: China is still the top conversation starter at BIO

4 weeks ago

Actio gets $66M for experimental epilepsy and Charcot-Marie-Tooth treatments

4 weeks ago

Sanofi-backed Welsh biotech secures $140M for neuropsychiatry pipeline

4 weeks ago

Members of Congress oppose NIH's payment cut plan, urge appeals court to maintain block

4 weeks ago

Orphan drug, PBM changes are excluded from Senate version of Trump tax bill

4 weeks ago

FDA approves CSL’s prophylactic for severe swelling condition

4 weeks ago

FDA unveils one-year pilot to speed some new drugs to market in just one month

4 weeks ago

After a quiet year, Xaira unwraps some of its AI research, eyeing a virtual cell

4 weeks ago

Lyell’s lymphoma data for recently acquired CAR-T receive lukewarm reception on Wall Street

4 weeks ago

First page Previous page 5 6 789 10 11 Next page Last page